Skip to content
healthcare.dev

IMATINIB MESYLATE

NDC 82249-021, IMATINIB MESYLATE, tablet, film coated, from Civica Script LLC.

Product NDC
82249-021
Status
Listed
Labeler
Civica Script LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212975
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82249-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE400 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
82249-021-308224900213030 TABLET, FILM COATED in 1 BOTTLE (82249-021-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fc5ec7b-98c4-4b1a-890c-be1343177dbd
  • NADAC price for package 82249002130

    GET /v1/drugs/nadac/82249002130

Use it

Look up 82249-021 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82249-021 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82249-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.